Abstract
Macrophages mediate the first line of defense in the host against various intracellular pathogens. They are armed with several immune-effector mechanisms to detect and combat pathogens. However, intracellular pathogens have developed strategies to overcome the macrophage protective immune responses and colonize inside the macrophages. Tuberculosis (TB), both pulmonary and extrapulmonary, is an infectious disease of global concern caused by Mycobacterium tuberculosis. M. tuberculosis is a highly successful pathogen and has acquired various strategies to downregulate critical innate-effector immune responses of macrophages such as phagosome-lysosome fusion, antigen presentation, autophagy, and inhibition of reactive oxygen (ROI) and reactive nitrogen (RNI) species to ensure its longer survival inside the macrophages. In addition to these, the bacilli also modulate T cell immune response which can help the bacilli to survive inside the host for a long time. In this chapter, we focus to describe important macrophage innate defense mechanisms and the signaling that can influence T cell adaptive response and the strategies adopted by the bacilli to exploit these signaling cascades to favor its replication and persistence inside the macrophages for establishing a productive infection.
Keywords
- Mycobacterium tuberculosis
- monocytes/macrophages
- macrophage effector response and signaling cascades
- host responses and M. tuberculosis pathogenesis
1. Introduction
Macrophages mediate the first line of defense in the host against various intracellular pathogens [1]. They are armed with several immune-effector mechanisms to detect and combat pathogens [2, 3]. However, intracellular pathogens have developed strategies to overcome the macrophage protective immune responses and colonize inside the macrophages. Tuberculosis (TB), is an infectious disease caused by a extremely successful pathogen,
2. Monocytes/macrophages
2.1. History and development
Eli Metchnikoff’s obsession, the “phagocyte” [phagos-to eat, cyte-cell], is a constituent of Ludwig Aschoff’s reticuloendothelial system (RES) [8]; the macrophage plays a key role at almost all the stages of immune response including innate and adaptive immune responses. Macrophages provide the first line of defense against the invading pathogens. In addition to protecting the body against attacks by foreign organisms, macrophages regulate important physiological functions. Their role in homeostasis has been well established. Macrophages clear almost 2 × 1011 erythrocytes per day. This enormous metabolic turnover is crucial for iron homeostasis and to prevent formation of toxic intermediates [9]. Macrophages are equipped with scavenger receptors such as phosphatidylserine receptors, thrombospondin receptor, integrins, and complement receptors to clear the cell debris and rapidly remove the apoptotic cells to help in tissue-remodeling processes. Antigens from the engulfed cells are presented along with the MHC molecules to activate the adaptive immune responses [10]. Thus, macrophage serves as a professional scavenger of the dying cells that not only clears the corpus but also regulates the immune system.
The circulating monocytes that are considered to be the developmental intermediates between bone marrow precursors and tissue macrophages emigrate from the blood vessels and differentiate into tissue macrophages [11]. Macrophages and monocytes originate from hematopoietic stem cell-derived progenitors with myeloid-restricted differentiation potential [1]. The bone marrow progenitors, monocytes, and macrophages collectively were classified into mononuclear phagocytic system, a concept pioneered by van Furth [12]. Monocytes are initially identified by the expression of CD14 molecules and lack of CD16 expression on the surface. These monocytes are termed as “classical monocytes” with CD14++CD16− phenotype and accounting for about 90% of human blood monocytes. However, later studies have proved the expression of CD16 on the surface of some cell populations that were termed as “non-classical monocytes” with CD14+CD16++ phenotype [13]. The replenishment of tissue macrophages with the circulating monocytes is well established, but in some instances like in microglial cells of brain, local proliferation of macrophages has been established. Owing to the adaptability and plasticity of macrophages and their responsiveness to different microenvironments in different tissues such as lung, spleen, liver, gut, and brain, a considerable heterogeneity exists among them [14]. For example, lung alveolar macrophages being constantly exposed to a variety of antigens, express a high level of pattern recognition receptors and scavenger receptors on the surface. In contrast, the macrophages of the gut exhibit high levels of phagocytic and antibacterial activities compared to other macrophages [15].
2.2. Macrophage activation
Activation is defined as the acquisition of competence to execute a complex function [16]. The factor responsible for macrophage activation was found to be the interferon-gamma (IFN-γ) produced by CD8+ cytotoxic T (Tc1) cells, CD4+ T helper 1 (Th1) T cells, and natural killer (NK) cells. IFN-γ activation leads to conversion of macrophages to potent phagocytotic cells with increased production of reactive oxygen intermediates and reactive nitrogen intermediates, superoxides and proinflammatory cytokines helping the cells to efficiently kill the intracellular pathogens. These macrophages have increased antigen presentation activity, thus they mount an effective immune responses in the host. The IFN-γ-mediated activation is known as “classical activation” and the macrophages are classified as “type 1 or M1 macrophages” [3, 18] (Figure 1). IFN-γ stimulation is not enough for the classical activation of macrophages, and may require additional stimulation by TNF-α. As TNF-α is not constitutively present in the environment, specific receptor ligands like lipopolysaccharides (LPS) and various microbial ligands may help in the induction of endogenous expression of TNF-α in macrophages [19, 20].
The T helper 2 (Th2) type of cytokines, IL-4 and IL-13, induce a response distinct from the one induced by IFN-γ with distinct set of genes being expressed and is known as “alternative activation” pathway of macrophages, and the cells are named as “alternative activated type 2 or M2 macrophages” [21]. In addition to T cells and B cells, IL-4 and IL-13 are also produced by various other cells such as mast cells, basophils, eosinophils, NK T cells, and macrophages that are involved in regulation of innate immune responses. Hence, alternative activation can be of both innate and acquired origin. Other than these two cytokines, immune complexes, IL-10, glucocorticoid, or secosteroid (vitamin D3) hormone can also contribute to the activation of M2 macrophages [22, 23, 24, 25]. M2 macrophages are characterized by expression of scavenger, mannose [26], and galactose-type receptors, and markers such as dectin-1, arginase 1, Ym1, and FIZZ1 [27]. The M2 macrophages have anti-inflammatory properties and are associated with allergic and anti-parasite responses, and are thought to regulate humoral immunity [27, 28]. The alternatively activated macrophages are found to be recruited to wounds and other sites of tissue injury and are programmed to perform a wound healing function by expressing arginase. These macrophages are termed as “repair macrophages” or “wound healing macrophages” [19, 29, 30]. The M1 and M2 macrophages thus represent two populations of cells with different biological functions [31]. For example, the M1 macrophages, but not the M2 macrophages, produce high levels of reactive oxygen and nitrogen intermediates) and inflammatory cytokines (IL-1β, TNF-α, IL-6), and have low arginase activity, express relatively high levels of CD86, and are efficient APCs. While the M1 cells have an IL-12high, IL-23high, and IL-10low phenotype and play an important role in inducing a dominant Th1 response and provide resistance against intracellular pathogens and tumors [17, 23, 32, 33, 34], the various forms of M2 macrophages share an IL-12low and IL-23low phenotype, virtually devoid of the co-stimulatory molecules and fail to mount a strong T cell proliferation [35, 36]. The innate and adaptive immune responses can also lead to the production of the “regulatory macrophages” (M reg) (Figure 1). The M reg cells are shown to be very stable in their phenotype and have regulatory activity. These cells are a novel type of suppressor macrophage which induces tolerance during organ transplantation. They have potent T cell suppressive function [37] and inhibit production of the IL-12 cytokine [38].
The activated macrophages exhibit a profound change in their capacities and functions. In addition to other physiological changes, there is a rapid membrane turnover found in case of macrophages even in the resting stage. This membrane flow is enormously increased in the activated state as a result of enhanced phagocytic activity and lysosomal degradation of the ingested material [39, 40]. Phagosomes undergo a series of maturation steps resulting in gradual acidification and increase in the hydrolytic activity. In addition to hydrolases, lethal superoxide generating enzyme activities become prevalent toward the end of phagosome maturation [40]. The NADPH oxidase activity of the enzyme complex leads to formation of H2O2 in presence of superoxide dismutase enzyme [41].
3. M. tuberculosis : infection and disease
Mycobacteria are rod-shaped bacteria of phylum Actinobacteria mostly found in soil or water. The
TB is a major public health burden. Despite the availability of effective short-course chemotherapy (DOTS) and
After infection with
4. Infection of macrophages with M. tuberculosis and host immune responses
4.1. The host-bacilli interplay
4.2. Formation of granuloma
4.3. Phagosome maturation response
After phagocytosis,
The transport of
A family of IFN-γ-inducible GTPases, also called immunity-related GTPases (IRGs), was found to play a critical role in host innate immunity against intracellular pathogens [100, 101, 102]. A member of IRG family, 47 kDa Irgm1 (also called LRG-47) protein (which is strongly inducible by IFN-γ and
4.4. Autophagy
Autophagy (also called xenophagy) is an evolutionary conserved basic homeostatic mechanism of a cell to digest intracellular organelles and large protein aggregates that are difficult to digest by normal proteasomal pathway. The engagement of TLRs with mycobacterial ligands induces autophagy using both MyD88-dependent and TRIF-dependent pathways [106, 107]. This suggests that autophagy is an effector of innate immune response. The IFN-γ induces IRG proteins that are mainly involved in induction of autophagy and elimination of
4.5. Apoptosis
Macrophages use apoptosis as an effector mechanism to eliminate
4.6. Reactive oxygen and nitrogen intermediates (ROIs and RNIs)
ROIs and RNIs are produced in cells like macrophages in response to proinflammatory cytokines [127, 128]. ROIs and RNIs being small molecules defuse easily through the membranes and have a detrimental effect on the pathogens been engulfed in phagocytic vacuoles [129]. Studies have indicated that these molecules are important in providing innate host defense against
Like other effector mechanisms,
The DosR is characterized as a transcription factor responsible for transcription of the genes in response to oxidative stress. Genes expressed during the stress response, like α-crystallin was shown to carry sequences in the regulatory regions for DosR binding. In response to upstream activation signals, DosR is phosphorylated at Asp54 that results in its binding to DNA via its C-terminal domain and subsequent activation of DosR responsive genes. The sensor kinases, DosS and DosT, respond to redox environment and hypoxia, respectively. Both the proteins contain two GAF domains at N-terminal harboring a heme prosthetic group which interacts with O2, NO or CO to induce autophosphorylation of the kinases and induce transcription of genes by activating DosR (Figure 5). CO is produced by heme oxygenase (HO) enzyme of macrophages. The enzyme is significantly upregulated during
4.7. Vitamin D3
Vitamin D has long been known to be one of the nutritional therapeutic agents with a capacity to modulate the immune system in the case of an
The mechanisms for a correlation of Vitamin D and TB are unknown, but it could be the antimicrobial peptides in association of Vitamin D generated by the pattern receptor stimulation in lieu of an infection with
5. Conclusion
TB remains a global pandemic and despite thorough and constructive measures to eradicate TB, it has flourished and continues killing people. It has evolved into various MDR, XDR, and TDR strains, notwithstanding the best healthcare available, which are resistant to the obsolete group of drugs. This necessitates the need to find new drug targets as well as drugs to counter the menace of TB. Therefore, it becomes imperative to understand the biology of
References
- 1.
Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010; 327 (5966):656-661 - 2.
Mackaness GB. The immunological basis of acquired cellular resistance. The Journal of Experimental Medicine. 1964; 120 :105-120 - 3.
Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Frontiers in Bioscience: a Journal and Virtual Library. 2008; 13 :453 - 4.
Flynn JL, Chan J. Immunology of tuberculosis. Annual Review of Immunology. 2001; 19 :93-129 - 5.
Flynn JL, Chan J. Immune evasion by Mycobacterium tuberculosis : Living with the enemy. Current Opinion in Immunology. 2003;15 (4):450-455 - 6.
Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis : Is death an exit strategy? Nature Reviews Microbiology. 2010;8 (9):668-674 - 7.
Jozefowski S, Sobota A, Kwiatkowska K. How Mycobacterium tuberculosis subverts host immune responses. BioEssays. 2008;30 (10):943-954 - 8.
Tauber AI. Metchnikoff and the phagocytosis theory. Nature Reviews Molecular Cell Biology. 2003; 4 (11):897-901 - 9.
De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: Consequences for iron-linked disorders. Nature Reviews Molecular Cell Biology. 2008; 9 (1):72-81 - 10.
Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000; 407 (6805):784-788 - 11.
Ebert R, Florey H. The extravascular development of the monocyte observed in vivo. British Journal of Experimental Pathology. 1939; 20 (4):342 - 12.
van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. The Journal of Experimental Medicine. 1968; 128 (3):415-435 - 13.
Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011; 118 (5):e16-e31 - 14.
Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ. Unravelling mononuclear phagocyte heterogeneity. Nature Reviews Immunology. 2010; 10 (6):453-460 - 15.
Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. The Journal of Clinical Investigation. 2005; 115 (1):66-75 - 16.
Adams DO. Molecular interactions in macrophage activation. Immunology Today. 1989; 10 (2):33-35 - 17.
Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. The Journal of Experimental Medicine. 1983; 158 (3):670-689 - 18.
O'Shea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity. 2008; 28 (4):477-487 - 19.
Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008; 8 (12):958-969 - 20.
Schroder K, Sweet MJ, Hume DA. Signal integration between IFNγ and TLR signalling pathways in macrophages. Immunobiology. 2006; 211 (6–8):511-524 - 21.
Gordon S, Martinez FO. Alternative activation of macrophages: Mechanism and functions. Immunity. 2010; 32 (5):593-604 - 22.
Gordon S. Alternative activation of macrophages. Nature Reviews Immunology. 2003; 3 (1):23-35 - 23.
Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P, et al. Alternative versus classical activation of macrophages. Pathobiology. 1999; 67 (5–6):222-226 - 24.
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology. 2002; 23 (11):549-555 - 25.
Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunology. 2010; 11 (10):936-944 - 26.
Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. The Journal of Experimental Medicine. 1992; 176 (1):287-292 - 27.
Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, Hassanzadeh Gh G. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. Journal of Leukocyte Biology. 2002; 71 (4):597-602 - 28.
Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, Voehringer D, et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature. 2007; 447 (7140):92-96 - 29.
Raes G, Beschin A, Ghassabeh GH, De Baetselier P. Alternatively activated macrophages in protozoan infections. Current Opinion in Immunology. 2007; 19 (4):454-459 - 30.
Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE. The phenotype of murine wound macrophages. Journal of Leukocyte Biology. 2010; 87 (1):59-67 - 31.
Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. Journal of Leukocyte Biology. 2006; 80 (6):1298-1307 - 32.
Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science. 1993; 259 (5102):1739-1742 - 33.
Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. Journal of Immunology. 2000; 164 (12):6166-6173 - 34.
Mosser DM. The many faces of macrophage activation. Journal of Leukocyte Biology. 2003; 73 (2):209-212 - 35.
Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: Competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. Journal of Immunology. 1998; 160 (11):5347-5354 - 36.
Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. Journal of Immunology. 2006; 177 (10):7303-7311 - 37.
Hutchinson JA, Riquelme P, Geissler EK, Fandrich F. Human regulatory macrophages. Methods in Molecular Biology. 2011; 677 :181-192 - 38.
Gerber JS, Mosser DM. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors. Journal of Immunology. 2001; 166 (11):6861-6868 - 39.
Ogmundsdottir HM, Weir DM. Stimulation of phosphatidylinositol turnover in the macrophage plasma membrane: A possible mechanism for signal transmission. Immunology. 1979; 37 (3):689-696 - 40.
Adams DO, Hamilton TA. The cell biology of macrophage activation. Annual Review of Immunology. 1984; 2 (1):283-318 - 41.
Russell DG, Vanderven BC, Glennie S, Mwandumba H, Heyderman RS. The macrophage marches on its phagosome: Dynamic assays of phagosome function. Nature Reviews Immunology. 2009; 9 (8):594-600 - 42.
Huard RC, Fabre M, De Haas P, Lazzarini LCO, van Soolingen D, Cousins D, et al. Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex. Journal of Bacteriology. 2006;188 (12):4271-4287 - 43.
Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proceedings of the National Academy of Sciences. 2002;99 (6):3684-3689 - 44.
Alexander KA, Laver PN, Michel AL, Williams M, van Helden PD, Warren RM, et al. Novel Mycobacterium tuberculosis complex pathogen,M .mungi . Emerging Infectious Diseases. 2010;16 (8):1296 - 45.
Murray JF. Mycobacterium tuberculosis and the cause of consumption from discovery to fact. American Journal of Respiratory and Critical Care Medicine. 2004;169 (10):1086-1088 - 46.
Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends in Microbiology. 2002;10 (1):45-52 - 47.
Glynn JR, Whiteley J, Bifani PJ, Kremer K, Van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis : A systematic review. Emerging Infectious Diseases. 2002;8 (8):843 - 48.
Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC. Drug resistance in Mycobacterium tuberculosis . Current Issues in Molecular Biology. 2006;8 (2):97-111 - 49.
Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Totally drug-resistant tuberculosis in India. Clinical Infectious Diseases. 2012; 54 (4):579-581 - 50.
Gillespie SH. Evolution of drug resistance in Mycobacterium tuberculosis : Clinical and molecular perspective. Antimicrobial Agents and Chemotherapy. 2002;46 (2):267-274 - 51.
Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, McHugh TD, et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. Journal of Infectious Diseases. 2012; 205 (Suppl 2):S228-S240 - 52.
Raviglione M. XDR-TB: Entering the post-antibiotic era? The International Journal of Tuberculosis and Lung Disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2006; 10 (11):1185 - 53.
Sutcliffe IC. Cell envelope composition and organisation in the genus Rhodococcus. Antonie Van Leeuwenhoek. 1998; 74 (1–3):49-58 - 54.
Minnikin DE, Kremer L, Dover LG, Besra GS. The methyl-branched fortifications of Mycobacterium tuberculosis . Chemistry & Biology. 2002;9 (5):545-553 - 55.
Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clinical Microbiology Reviews. 2003;16 (3):463-496 - 56.
Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: Implications for new vaccines. Nature Reviews Immunology. 2005; 5 (8):661-667 - 57.
Bloom BR, editor. Tuberculosis: Pathogenesis, Protection and Control. N. W: American Society for Microbiology; 1994 - 58.
Tatar D, Senol G, Alptekin S, Karakurum C, Aydin M, Coskunol I. Tuberculosis in diabetics: Features in an endemic area. Japanese Journal of Infectious Diseases. 2009; 62 (6):423-427 - 59.
Fatkenheuer G, Taelman H, Lepage P, Schwenk A, Wenzel R. The return of tuberculosis. Diagnostic Microbiology and Infectious Disease. 1999; 34 (2):139-146 - 60.
Lawn SD, Wood R, Wilkinson RJ. Changing concepts of “latent tuberculosis infection” in patients living with HIV infection. Clinical and Developmental Immunology. 2011; 2011 - 61.
Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: Epidemiology and strategies for prevention. Tubercle and Lung Disease. 1992; 73 (6):311-321 - 62.
Kaufmann SH. Recent findings in immunology give tuberculosis vaccines a new boost. Trends in Immunology. 2005; 26 (12):660-667 - 63.
Dannenberg AM. Pathogenesis of Human Pulmonary Tuberculosis: Insights from the Rabbit Model. N. W: American Society for Microbiology; 2006 - 64.
Nienhaus A, Schablon A, Diel R. Interferon-γ release assay for the diagnosis of latent TB infection--analysis of discordant results, when compared to the tuberculin skin test. PLoS One. 2008; 3 (7):e2665 - 65.
Miranda C, Tomford JW, Gordon SM. Interferon-γ-release assays: Better than tuberculin skin testing? Cleveland Clinic Journal of Medicine. 2010; 77 (9):606-611 - 66.
Pai M, Zwerling A, Menzies D. Systematic review: T-cell–based assays for the diagnosis of latent tuberculosis infection: An update. Annals of Internal Medicine. 2008; 149 (3):177 - 67.
Gannon BW, Hayes CM, Roe JM. Survival rate of airborne Mycobacterium bovis . Research in Veterinary Science. 2007;82 (2):169-172 - 68.
Hickman C, MacDonald KL, Osterholm MT. Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995. Morbidity and Mortality Weekly Report. 1995;44 (8):137-140 - 69.
Ernst JD. Macrophage receptors for Mycobacterium tuberculosis . Infection and Immunity. 1998;66 (4):1277-1281 - 70.
Vergne I, Chua J, Singh SB, Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annual Review of Cell and Developmental Biology. 2004;20 :367-394 - 71.
Pasula R, Downing JF, Wright JR, Kachel DL, Davis Jr TE, Martin W 2nd. Surfactant protein a (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. American Journal of Respiratory and Critical Care Medicine. 1997;17 (2):209 - 72.
Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, Amara A, et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. The Journal of Experimental Medicine. 2003;197 (1):121-127 - 73.
Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. Journal of Immunology. 1993;150 (7):2920-2930 - 74.
Schlesinger LS, Hull SR, Kaufman TM. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. Journal of Immunology. 1994;152 (8):4070-4079 - 75.
Geijtenbeek TBH, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CMJE, Appelmelk B, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. The Journal of Experimental Medicine. 2003; 197 (1):7-17 - 76.
Mukhopadhyay S, Nair S, Ghosh S. Pathogenesis in tuberculosis: Transcriptomic approaches to unraveling virulence mechanisms and finding new drug targets. FEMS Microbiology Reviews. 2012; 36 (2):463-485 - 77.
Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 2001; 291 (5508):1544-1547 - 78.
Court N, Vasseur V, Vacher R, Fremond C, Shebzukhov Y, Yeremeev VV, et al. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. Journal of Immunology. 2010;184 (12):7057-7070 - 79.
Russell DG. Who puts the tubercle in tuberculosis? Nature Reviews Microbiology. 2007; 5 (1):39-47 - 80.
Schluger NW, Rom WN. The host immune response to tuberculosis. American Journal of Respiratory and Critical Care Medicine. 1998; 157 (3 Pt 1):679-691 - 81.
Cooper AM. Cell-mediated immune responses in tuberculosis. Annual Review of Immunology. 2009; 27 :393-422 - 82.
Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. The Journal of Experimental Medicine. 2001;193 (3):271-280 - 83.
Grotzke JE, Lewinsohn DM. Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes and Infection. 2005;7 (4):776-788 - 84.
Ulrichs T, Kaufmann SH. New insights into the function of granulomas in human tuberculosis. The Journal of Pathology. 2006; 208 (2):261-269 - 85.
Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell. 2009; 136 (1):37-49 - 86.
Capuano SV, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of humanM. tuberculosis infection. Infection and Immunity. 2003;71 (10):5831-5844 - 87.
Vergne I, Chua J, Lee HH, Lucas M, Belisle J, Deretic V. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis . Proceedings of the National Academy of Sciences. 2005;102 (11):4033-4038 - 88.
Festjens N, Bogaert P, Batni A, Houthuys E, Plets E, Vanderschaeghe D, et al. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis . EMBO Molecular Medicine. 2011;3 (4):222-234 - 89.
Grundner C, Ng HL, Alber T. Mycobacterium tuberculosis protein tyrosine phosphatase PtpB structure reveals a diverged fold and a buried active site. Structure. 2005;13 (11):1625-1634 - 90.
Via LE, Deretic D, Ulmer RJ, Hibler NS, Huber LA, Deretic V. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. Journal of Biological Chemistry. 1997; 272 (20):13326-13331 - 91.
Deretic V, Singh S, Master S, Harris J, Roberts E, Kyei G, et al. Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cellular Microbiology. 2006;8 (5):719-727 - 92.
Pieters J. Mycobacterium tuberculosis and the macrophage: Maintaining a balance. Cell Host & Microbe. 2008;3 (6):399-407 - 93.
Tan T, Lee WL, Alexander DC, Grinstein S, Liu J. The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation. Cellular Microbiology. 2006;8 (9):1417-1429 - 94.
Pethe K, Swenson DL, Alonso S, Anderson J, Wang C, Russell DG. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proceedings of the National Academy of Sciences. 2004;101 (37):13642-13647 - 95.
Stewart GR, Patel J, Robertson BD, Rae A, Young DB. Mycobacterial mutants with defective control of phagosomal acidification. PLoS Pathogens. 2005; 1 (3):269-278 - 96.
Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell. 1999; 97 (4):435-447 - 97.
Jayachandran R, Sundaramurthy V, Combaluzier B, Mueller P, Korf H, Huygen K, et al. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell. 2007; 130 (1):37-50 - 98.
Blackwell JM, Searle S, Goswami T, Miller EN. Understanding the multiple functions of Nramp1. Microbes and Infection. 2000; 2 (3):317-321 - 99.
Hackam DJ, Rotstein OD, Zhang W, Gruenheid S, Gros P, Grinstein S. Host resistance to intracellular infection: Mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. The Journal of Experimental Medicine. 1998; 188 (2):351-364 - 100.
MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science. 2003; 302 (5645):654-659 - 101.
Taylor GA, Feng CG, Sher A. p47 GTPases: Regulators of immunity to intracellular pathogens. Nature Reviews Immunology. 2004; 4 (2):100-109 - 102.
Taylor GA. IRG proteins: Key mediators of interferon-regulated host resistance to intracellular pathogens. Cellular Microbiology. 2007; 9 (5):1099-1107 - 103.
Kyei GB, Vergne I, Chua J, Roberts E, Harris J, Junutula JR, et al. Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrest. The EMBO Journal. 2006;25 (22):5250-5259 - 104.
Tiwari S, Choi HP, Matsuzawa T, Pypaert M, MacMicking JD. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nature Immunology. 2009; 10 (8):907-917 - 105.
Kuijl C, Neefjes J. New insight into the everlasting host-pathogen arms race. Nature Immunology. 2009; 10 (8):808-809 - 106.
Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunological Reviews. 2011; 240 (1):92-104 - 107.
Harris J, Hope J, Lavelle E. Autophagy and the immune response to TB. Transboundary and Emerging Diseases. 2009; 56 (6–7):248-254 - 108.
Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science. 2006; 313 (5792):1438-1441 - 109.
King KY, Lew JD, Ha NP, Lin JS, Ma X, Graviss EA, et al. Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS One. 2011; 6 (1):e16317 - 110.
Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011; 469 (7330):323-335 - 111.
Kumar D, Nath L, Kamal MA, Varshney A, Jain A, Singh S, et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis . Cell. 2010;140 (5):731-743 - 112.
Harris J, De Haro SA, Master SS, Keane J, Roberts EA, Delgado M, et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis . Immunity. 2007;27 (3):505-517 - 113.
Ni Cheallaigh C, Keane J, Lavelle E, Hope J, Harris J. Autophagy in the immune response to tuberculosis: Clinical perspectives. Clinical and Experimental Immunology. 2011; 164 (3):291-300 - 114.
Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. Journal of Immunology. 2000;164 (4):2016-2020 - 115.
Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis . Nature Immunology. 2010;11 (8):751-758 - 116.
Behar S, Martin C, Booty M, Nishimura T, Zhao X, Gan H, et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis . Mucosal Immunology. 2011;4 (3):279-287 - 117.
Spira A, Carroll JD, Liu G, Aziz Z, Shah V, Kornfeld H, et al. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis : A pivotal role for tumor necrosis factor. American Journal of Respiratory and Critical Care Medicine. 2003;29 (5):545-551 - 118.
Sly LM, Hingley-Wilson SM, Reiner NE, McMaster WR. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. Journal of Immunology. 2003;170 (1):430-437 - 119.
Dhiman R, Raje M, Majumdar S. Differential expression of NF-κB in mycobacteria infected THP-1 affects apoptosis. Biochimica et Biophysica Acta. 2007; 1770 (4):649-658 - 120.
Dhiman R, Kathania M, Raje M, Majumdar S. Inhibition of bfl-1/A1 by siRNA inhibits mycobacterial growth in THP-1 cells by enhancing phagosomal acidification. Biochimica et Biophysica Acta. 2008; 1780 (4):733-742 - 121.
Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis . Journal of Immunology. 1998;160 (11):5448-5454 - 122.
Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. Journal of Immunology. 1998;161 (5):2636-2641 - 123.
Velmurugan K, Chen B, Miller JL, Azogue S, Gurses S, Hsu T, et al. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathogens. 2007;3 (7):e110 - 124.
Miller JL, Velmurugan K, Cowan MJ, Briken V. The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-α-mediated host cell apoptosis. PLoS Pathogens. 2010;6 (4):e1000864 - 125.
Jayakumar D, Jacobs WR Jr, Narayanan S. Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection. Cellular Microbiology. 2008;10 (2):365-374 - 126.
Hinchey J, Jeon BY, Alley H, Chen B, Goldberg M, Derrick S, et al. Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis. PLoS One. 2011; 6 (1):e15857 - 127.
Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. Journal of Immunology. 1988; 141 (7):2407-2412 - 128.
Sato K, Akaki T, Tomioka H. Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-γ (IFN-γ) and tumour necrosis factor-α (TNF-α). Clinical and Experimental Immunology. 1998; 112 (1):63-68 - 129.
Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proceedings of the National Academy of Sciences. 2000; 97 (16):8841-8848 - 130.
Jackson SH, Gallin JI, Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. The Journal of Experimental Medicine. 1995; 182 (3):751-758 - 131.
Adams L, Dinauer M, Morgenstern D, Krahenbuhl J. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tubercle and Lung Disease. 1997;78 (5):237-246 - 132.
Lau Y, Chan G, Ha S, Hui Y, Yuen K. The role of phagocytic respiratory burst in host defense. Clinical Infectious Diseases. 1998; 26 (1):226-227 - 133.
Shiloh MU, Nathan CF. Reactive nitrogen intermediates and the pathogenesis of salmonella and mycobacteria. Current Opinion in Microbiology. 2000; 3 (1):35-42 - 134.
Chan ED, Chan J, Schluger NW. What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. American Journal of Respiratory and Critical Care Medicine. 2001; 25 (5):606 - 135.
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proceedings of the National Academy of Sciences. 1997; 94 (10):5243-5248 - 136.
MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annual Review of Immunology. 1997; 15 :323-350 - 137.
Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR, Nathan C, Xie QW, Mumford R, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. The Journal of Experimental Medicine. 1996; 183 (5):2293-2302 - 138.
Wang CH, Lin HC, Liu CY, Huang KH, Huang TT, Yu CT, et al. Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. The International Journal of Tuberculosis and Lung Disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2001; 5 (3):283-291 - 139.
Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 1999; 285 (5428):732-736 - 140.
Miller BH, Fratti RA, Poschet JF, Timmins GS, Master SS, Burgos M, et al. Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infection and Immunity. 2004; 72 (5):2872-2878 - 141.
Davis AS, Vergne I, Master SS, Kyei GB, Chua J, Deretic V. Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. PLoS Pathogens. 2007; 3 (12):e186 - 142.
Master SS, Springer B, Sander P, Boettger EC, Deretic V, Timmins GS. Oxidative stress response genes in Mycobacterium tuberculosis : Role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. Microbiology. 2002;148 (Pt 10):3139-3144 - 143.
Heym B, Zhang Y, Poulet S, Young D, Cole ST. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis . Journal of Bacteriology. 1993;175 (13):4255-4259 - 144.
Manca C, Paul S, Barry CE 3rd, Freedman VH, Kaplan G. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infection and Immunity. 1999;67 (1):74-79 - 145.
Li Z, Kelley C, Collins F, Rouse D, Morris S. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and Guinea pigs. Journal of Infectious Diseases. 1998;177 (4):1030-1035 - 146.
Hu Y, Butcher PD, Mangan JA, Rajandream MA, Coates AR. Regulation of hmp gene transcription in Mycobacterium tuberculosis : Effects of oxygen limitation and nitrosative and oxidative stress. Journal of Bacteriology. 1999;181 (11):3486-3493 - 147.
Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the Phagosomal environment. The Journal of Experimental Medicine. 2003;198 (5):693-704 - 148.
Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. The Journal of Experimental Medicine. 2003;198 (5):705-713 - 149.
Ohno H, Zhu G, Mohan VP, Chu D, Kohno S, Jacobs WR Jr, et al. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis . Cellular Microbiology. 2003;5 (9):637-648 - 150.
Dasgupta N, Kapur V, Singh KK, Das TK, Sachdeva S, Jyothisri K, et al. Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis . Tubercle and Lung Disease. 2000;80 (3):141-159 - 151.
Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin. Proceedings of the National Academy of Sciences. 2001;98 (13):7534-7539 - 152.
Kendall SL, Movahedzadeh F, Rison SC, Wernisch L, Parish T, Duncan K, et al. The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses. Tuberculosis (Edinburgh, Scotland). 2004;84 (3–4):247-255 - 153.
Kumar A, Toledo JC, Patel RP, Lancaster JR Jr, Steyn AJ. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proceedings of the National Academy of Sciences. 2007;104 (28):11568-11573 - 154.
Kumar A, Deshane JS, Crossman DK, Bolisetty S, Yan BS, Kramnik I, et al. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. Journal of Biological Chemistry. 2008;283 (26):18032-18039 - 155.
Shiloh MU, Manzanillo P, Cox JS. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host & Microbe. 2008;3 (5):323-330 - 156.
Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. International Journal of Epidemiology. 2008; 37 (1):113-119 - 157.
Douglas AS, Strachan DP, Maxwell JD. Seasonality of tuberculosis: The reverse of other respiratory diseases in the UK. Thorax. 1996; 51 (9):944-946 - 158.
Strachan DP, Powell KJ, Thaker A, Millard FJ, Maxwell JD. Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax. 1995; 50 (2):175-180 - 159.
Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: A case-control study. Lancet. 2000; 355 (9204):618-621 - 160.
Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. Journal of Immunology. 2007;179 (4):2060-2063 - 161.
Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proceedings of the National Academy of Sciences. 2012; 109 (38):15449-15454 - 162.
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311 (5768):1770-1773 - 163.
Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, Wheelwright M, et al. Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009; 4 (6):e5810 - 164.
Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host & Microbe. 2009; 6 (3):231-243 - 165.
Anand SP, Selvaraj P. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis. Clinical Immunology. 2009; 133 (1):126-131 - 166.
Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Journal of Cellular Biochemistry. 2003; 89 (5):922-932 - 167.
Vidyarani M, Selvaraj P, Jawahar MS, Narayanan PR. 1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis. Cytokine. 2007; 40 (2):128-134 - 168.
Imazeki I, Matsuzaki J, Tsuji K, Nishimura T. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomedical Research. 2006; 27 (1):1-9 - 169.
Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Journal of Pharmacology and Experimental Therapeutics. 2008; 324 (1):23-33 - 170.
Cantorna MT, Humpal-Winter J, DeLuca HF. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Archives of Biochemistry and Biophysics. 2000; 377 (1):135-138 - 171.
Sly LM, Lopez M, Nauseef WM, Reiner NE. 1α,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. Journal of Biological Chemistry. 2001; 276 (38):35482-35493 - 172.
Anand PK, Kaul D. Vitamin D3-dependent pathway regulates TACO gene transcription. Biochemical and Biophysical Research Communications. 2003; 310 (3):876-877 - 173.
Anand PK, Kaul D. Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages. FEMS Microbiology Letters. 2005; 250 (1):137-144